Chembio Diagnostics, Inc.CE.MINASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank62
3Y CAGR-33.6%
5Y CAGR-5.8%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-33.6%/yr
Quarterly compound
5Y CAGR
-5.8%/yr
Recent deceleration
Percentile
P62
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.88% |
| Q3 2025 | 12.72% |
| Q2 2025 | -14.29% |
| Q1 2025 | -1.83% |
| Q4 2024 | 13.70% |
| Q3 2024 | -11.55% |
| Q2 2024 | -1.63% |
| Q1 2024 | 1.15% |
| Q4 2023 | 20.05% |
| Q3 2023 | -8.18% |
| Q2 2023 | 12.62% |
| Q1 2023 | 46.82% |
| Q4 2022 | 13.24% |
| Q3 2022 | -7.79% |
| Q2 2022 | -1.47% |
| Q1 2022 | -11.55% |
| Q4 2021 | 33.12% |
| Q3 2021 | -2.57% |
| Q2 2021 | -3.84% |
| Q1 2021 | 4.55% |
| Q4 2020 | 5.23% |
| Q3 2020 | 6.44% |
| Q2 2020 | -7.12% |
| Q1 2020 | -12.18% |
| Q4 2019 | 17.16% |
| Q3 2019 | -6.18% |
| Q2 2019 | 8.15% |
| Q1 2019 | -9.29% |
| Q4 2018 | 15.81% |
| Q3 2018 | -4.52% |
| Q2 2018 | -6.29% |
| Q1 2018 | -3.17% |
| Q4 2017 | 21.18% |
| Q3 2017 | -12.86% |
| Q2 2017 | 2.04% |
| Q1 2017 | -7.73% |
| Q4 2016 | 18.15% |
| Q3 2016 | -2.34% |
| Q2 2016 | -5.71% |
| Q1 2016 | -1.27% |